Insulin glargine compared to NPH among insulin-na?ve, U.S. inner city, ethnic minority type 2 diabetic patients.

Hsia SH. Insulin glargine compared to NPH among insulin-na?ve, U.S. inner city, ethnic minority type 2 diabetic patients. Diabetes Res Clin Pract. 2011 Mar; 91(3):293-9.

View in: PubMed

subject areas

Adolescent
Adult
Aged
Blood Glucose
Circadian Rhythm
Cities
Diabetes Mellitus, Type 2
Humans
Hypoglycemic Agents
Insulin
Insulin, Long-Acting
Maximum Tolerated Dose
Middle Aged
Minority Groups
Treatment Outcome
Weight Gain
Young Adult

authors with profiles

Stanley H. Hsia, MD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support